A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is a Phase II/III clinical trial, aimed to evaluate the efficacy and safety ofEnlituo® combined with Anyouping® plus platinum and nab‐paclitaxel chemotherapy asfirst‐line therapy for advanced, recurrent or metastatic HNSCC.Phase II Part Approximately 60 participants will be enrolled and randomly assigned at a1:1 ratio to the experimental group.Phase III Part Approximately 302 participants will be enrolled and randomly assigned in a1:1 double‐blind manner to the experimental group.
Epistemonikos ID: e90955b90b280ea06f3d0cd795b3d2edf7920f5b
First added on: Aug 29, 2026